Professional Documents
Culture Documents
Prevention Strategies and Ischemic Stroke Management
Prevention Strategies and Ischemic Stroke Management
Webinar
15
15 Agustus
Agustus 2021
2021
PREVENTION
STRATEGIES AND
ISCHEMIC STROKE
MANAGEMENT
Fakultas
Fakultas Kedokteran
Kedokteran
Universitas
Universitas Sumatera
Sumatera Utara
Utara 1
Outline
1 Introduction
Acute Additional
Additionaltreatment
treatmentw/
w/
Acute
reperfusion mechanical
mechanicalthrombectomy
thrombectomy
reperfusion
The Severe
Severeneurologic
neurologicdeficit
deficitfrom
Themost
mosteffective
effective from
treatment aaproximal
proximalintracranial
intracranialvessel
treatmentfor
foracute
acute vessel
ischemic occlusion
ischemicstroke
stroke occlusion
Rabinstein AA. Update on Treatment of Acute Ischemic Stroke. Contin Lifelong Learn Neurol. 2020;268–86.
Patel A, Berdunov V, King D, Quayyum Z, Wittenberg R, Knapp M. Current , future and avoidable costs of stroke in the UK.
Webinar | Prevention
Overview ofStrategies
Diagnosticand
Approach
Ischemicand Management
Stroke in Ischemic Stroke
Management 11
AHA’s My Life Check –
Life’s Simple 7.
Seven approaches to
staying heart healthy
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS,
Callaway CW, Carson AP, et al. Heart disease and stroke
statistics—2020 update: A report from the American
Heart Association. Circulation. 2020. 139–596 p.
15
TIME IS BRAIN, SAVE THE PENUMBRA
16
Webinar | Prevention Strategies and Ischemic Stroke Management 16
Outline
Principles of Acute Stroke
Three
Threemain
mainprinciples
principles
Recanalization
Recanalizationand
and Opening
Openingthe
theoccluded
occluded Reduce
Reduceinfarct
infarctsize
size&&
reperfusion
reperfusion artery
artery reverse
reverseneurologic
neurologicdeficit
deficit
Optimize
Optimizecollateral
collateral Keeping
Keepingthe
theischemic
ischemic Prevent
Preventcritical
criticalischemia
ischemia&&
flow penumbra
penumbraviable
viable infarction
flow infarction
But not sufficient
Avoid
Avoidsecondary
secondarybrain Maintain
brain Maintainnormal
normalcellular
cellular
injury
injury function
function
Rabinstein AA. Update on Treatment of Acute Ischemic Stroke. Contin Lifelong Learn Neurol. 2020;268–86.
17
Webinar | Prevention Strategies and Ischemic Stroke Management 17
SAVE THE PENUMBRA !!!!
penumbra
core
18
Webinar | Prevention Strategies and Ischemic Stroke Management
1. Acute therapy and optimization of neurological status
19
Webinar | Prevention Strategies and Ischemic Stroke Management
Outline
Acute Reperfusion Treatments : Intravenous Thrombolysis
Effective
Effectiveininimproving
improving After
Afteran
anischemic
ischemic
IVIVthrombolysis
thrombolysiswith
withrtPA
rtPA outcomes
outcomes stroke
stroke
Up
Uptoto33hours
hoursafter
after Up
Uptoto4,5
4,5hours
hoursafter
after
US
USFDA
FDA symptom
symptomonset
onset symptom
symptomonset
onset
AHA/American
Eligible Sroke Association
Initial Eligiblefor
forreperfusion
reperfusion
Initialevaluation
evaluation therapy
therapy
After
Aftersymptom
symptomonset,
onset,medical
medicalcondition
conditionthat
thatcould
couldcontraindicate
contraindicatethrombolysis,
thrombolysis,Neurologic
Neurologic
examination
examinationtotocalculate
calculatethe
the(NIHSS)
(NIHSS)score,
score,aacapillary
capillaryglucose
glucoselevel,
level,blood
bloodpressure,
pressure,and
andbrain
brain
imaging
imaging
Rabinstein AA. Update on Treatment of Acute Ischemic Stroke. Contin Lifelong Learn Neurol . 2020;268–86.
20
Webinar | Prevention Strategies and Ischemic Stroke Management
21
Webinar | Prevention Strategies and Ischemic Stroke Management
22
Webinar | Prevention Strategies and Ischemic Stroke Management
Graphic
Graphicillustrating
illustratingthe
thesequence
sequenceofofsteps
stepsinincontemporary
contemporaryacute
acutestroke
stroketherapy.
therapy.
Powers WJ, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018
guidelines for the early management of acute ischemic stroke., Stroke. 2019.
23
Webinar | Prevention Strategies and Ischemic Stroke Management
Powers WJ, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018
guidelines for the early management of acute ischemic stroke., Stroke. 2019.
24
Webinar | Prevention Strategies and Ischemic Stroke Management
Powers WJ, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018
guidelines for the early management of acute ischemic stroke., Stroke. 2019.
25
Webinar | Prevention Strategies and Ischemic Stroke Management
Stroke. 2014;45:e222-e225.
26
Webinar | Prevention Strategies and Ischemic Stroke Management
JAMA Neurol,March 2019
Of the 503 patients randomized in theWAKE-UP trial, 108 patients (74 men [68.5%]) had
imaging-defined lacunar infarcts, whereas 395 patients (251 men [63.5%]) had
nonlacunar infarcts
CONCLUSIONS
The results indicate that the association of IV alteplase with functional
outcome does not differ in patients with imaging-defined lacunar infarcts
compared with those experiencing other stroke subtypes.
27
Webinar
Update in |Acute
Prevention Strategies
Ischemic Strokeand Ischemic Stroke Management
Treatment
IVIVrecombinant
recombinanttissue
tissueplasminogen
plasminogenactivator
activator(rtPA)
(rtPA)(alteplase)
(alteplase)for
foracute
acuteischemic
ischemicstroke
stroke
Rabinstein AA. Update on Treatment of Acute Ischemic Stroke. Contin Lifelong Learn Neurol. 2020;268–86.
28
Webinar | Prevention Strategies and Ischemic Stroke Management
PLOS ONE | DOI:10.1371/ 2015
Conclusion:
This meta-analysis determined that IAT conferred a significantly greater
probability of achieving a favorable outcome compared with IVT. There
was also a significant difference in mortality rates between IAT and IVT.
The studies included in this analysis were small and heterogeneous;
therefore, larger randomized prospective clinical studies are necessary
to further investigate this issue
29
Webinar | Prevention Strategies and Ischemic Stroke Management
30
Webinar | Prevention Strategies and Ischemic Stroke Management
Distribution
Distributionofofscores
scoreson
on90-d
90-dmodified
modifiedRankin
RankinScale
Scale
Koga M, et al. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset. Stroke. 2020;
31
Webinar | Prevention Strategies and Ischemic Stroke Management
1. Acute therapy and optimization of
neurological status (cont.d)
32
Webinar | Prevention Strategies and Ischemic Stroke Management
1. Acute therapy and optimization of
neurological status (cont.d)
33
Webinar | Prevention Strategies and Ischemic Stroke Management
2. Etiological work-up for secondary prevention
34
Webinar | Prevention Strategies and Ischemic Stroke Management
3. Prevention of neurological deterioration or medical
complications
• DVT prophylaxis
• Aspiration precautions
• Gastrointestinal ulcer prophylaxis
• Take out indwelling urinary catheter as soon as possible
• Monitor platelet counts if on heparin
35
Webinar | Prevention Strategies and Ischemic Stroke Management
4. Prevention of neurological deterioration or medical complications :
Drug therapy in the first 72 hours :
36
Webinar | Prevention Strategies and Ischemic Stroke Management
Outline
Antiplatelet treatment (AHA Recommendation)
Within
Within24-48
24-48hours
hoursafter
after
Administration
Administrationofofaspirin
aspirin onset
onset
Reducing
Reducingischemic
ischemicstroke
strokefor
foraa
For
Forthose
thosetreated
treatedwith
withIVIV Delayed
Delayeduntil
until24
24hours
hours period
periodup
uptoto90
90days
daysfrom
fromonset
onset
alteplase
alteplase
Within
Within24
24hrhrafter
aftersymptom
symptom
Minorcardioembolic
Minorcardioembolic Dual
Dualantiplatelet
antiplatelettherapy
therapy(aspirin
(aspirin onset
onsetand
andcontinued
continuedforfor21
21
ischemic
ischemicstroke
stroke(NIHSS
(NIHSS≤≤3)3) &&clopidogrel
clopidogrel days
days
Who did not receive IV alteplase
TPβ
TPβrec.
rec. TPα
TPαrec.
rec. P2Y
P2Y1212rec.
rec. PAR1
PAR1rec.
rec.
VASP
VASP VASP-P
VASP-P
GP
GPIIb/IIIa
IIb/IIIarec.
rec.activation
activation GP
GPIIb/IIIa
IIb/IIIarec.
rec.inactivation
inactivation
thrombocyte aggregation
thrombocyte aggregation thrombocyte stabilisation
thrombocyte stabilisation
38
Webinar | Prevention Strategies and Ischemic Stroke Management
The benefit of clopidogrel-aspirin occurs
predominantly within the first 21 days, and
outweighs the low, but ongoing risk
of major hemorrhage. When considered with the
results of the CHANCE trial (Clopidogrel in High-
Risk Patients With Non-disabling Cerebrovascular
Events), a similar trial treating with clopidogrel-
aspirin for 21 days and showing no increase in
major hemorrhage, these results suggest that
limiting clopidogrel-aspirin use to 21 days may
maximize
benefit and reduce risk after high-risk transient
ischemic attack or minor
ischemic stroke.
39
Webinar | Prevention Strategies and Ischemic Stroke Management
Time
Timecourse
courseofofthe
the
absolute treatment
absolute treatment
difference
difference
Johnston SC, et al. Time
Course for Benefit and Risk of
Clopidogrel and Aspirin After
Acute Transient Ischemic
Attack and Minor Ischemic
Stroke. Circulation. 2019
40
Webinar | Prevention Strategies and Ischemic Stroke Management
Hazard
Hazardrates
ratesby
byweek
weekafter
afterrandomization.
randomization.
Johnston SC, et al. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor
Ischemic Stroke. Circulation. 2019
41
Webinar | Prevention Strategies and Ischemic Stroke Management
Conclusion
Stroke remains a disease of immense public health significance in the 21stst
1
century despite the advances in our understanding